Pentylenetetrazole-induced kindling rat model: miR-182 and miR-27b-3p mediated neuroprotective effect of thymoquinone in the hippocampus

References

• Kobow K, Blümcke I. Epigenetics in epilepsy. Neurosci Lett. 2018;667:40–46.
   PubMed Web of Science ®Google Scholar
• Nakahara S, Adachi M, Ito H, et al. Hippocampal pathophysiology: commonality shared by temporal lobe epilepsy and psychiatric disorders. Neurosci J. 2018;2018:1–9. 2018.
   Google Scholar
• Kang KW, Kim W, Cho YW, et al. Genetic characteristics of non-familial epilepsy. PeerJ. 2019;7:e8278.
   PubMed Web of Science ®Google Scholar
• Brennan GP, Bauer S, Engel T, et al. Genome-wide microRNA profiling of plasma from three different animal models identifies biomarkers of temporal lobe epilepsy. Neurobiol Dis. 2020;144:105048.
   PubMed Web of Science ®Google Scholar
• Baloun J, Bencurova P, Totkova T, et al. Epilepsy miRNA profile depends on the age of onset in humans and rats. Front Neurosci. 2020;14:924.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.
   PubMed Web of Science ®Google Scholar
• de Planell-saguer M, Rodicio MC. Analytical aspects of microRNA in diagnostics: a review. Anal Chim Acta. 2011;699(2):134–152.
   PubMed Web of Science ®Google Scholar
• Prendecki M, Florczak-Wyspianska J, Kowalska M, et al. APOE genetic variants and apoE, miR-107 and miR-650 levels in Alzheimer’s disease. Folia Neuropathol. 2019;57(2):106–116.
   PubMed Web of Science ®Google Scholar
• Aronica E, Fluiter K, Iyer A, et al. Expression pattern of miR‐146a, an inflammation‐associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci. 2010;31(6):1100–1107.
   PubMed Web of Science ®Google Scholar
• Tiwari D, Peariso K, Gross C. MicroRNA‐induced silencing in epilepsy: opportunities and challenges for clinical application. Dev Dyn. 2018;247(1):94–110.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhao J. MicroRNA dysregulation in epilepsy: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development. Front Mol Neurosci. 2021;14:35.
   Web of Science ®Google Scholar
• Wang Y, Chen Z. An update for epilepsy research and antiepileptic drug development: toward precise circuit therapy. Pharmacol Ther. 2019;201:77–93.
   PubMed Web of Science ®Google Scholar
• Sousa DPD, Nóbrega FF, Santos CC, et al. Anticonvulsant activity of thymoquinone and its structural analogues. Revista Brasileira de Farmacognosia. 2011;21(3):427–431.
   Google Scholar
• Ijaz H, Tulain UR, Qureshi J, et al. Nigella sativa (prophetic medicine): a review. Pak J Pharm Sci. 2017;30:229–234. PMID: 28603137.
   Web of Science ®Google Scholar
• Desai S, Saheb SH, Das KK, et al. Phytochemical analysis of Nigella sativa and it’s antidiabetic effect. J. Pharm. Sci. Res. 2015;7:527.
   Google Scholar
• Boskabadi M, Shirmohammadi B Effect of Nigella sativa on isolated Guinea pig trachea . Archives Iranian Med. 2002;5:(2): 103–107. https://www.sid.ir/en/journal/ViewPaper.aspx?id=13035
   Google Scholar
• Meral I, Esrefoglu M, Dar KA, et al. Effects of Nigella sativa on apoptosis and GABAA receptor density in cerebral cortical and hippocampal neurons in pentylenetetrazol induced kindling in rats. Biotech Histochem. 2016;91(8):493–500.
   PubMed Web of Science ®Google Scholar
• Majeed A, Muhammad Z, Ahmad H, et al. Nigella sativa L.: uses in traditional and contemporary medicines–An overview . Acta Ecologica Sinica. 2020;41(4): 253–258. doi:https://doi.org/10.1016/j.chnaes.2020.02.001.
   Web of Science ®Google Scholar
• Imran M, Rauf A, Khan IA, et al. Thymoquinone: a novel strategy to combat cancer: a review. Biomed Pharmacother. 2018;106:390–402.
   PubMed Web of Science ®Google Scholar
• Badibostan H, Mehri S, Mohammadi E, et al. Protective effect of Thymoquinone on D-galactose-induced aging in mice. Jundishapur J Nat Pharm Prod. 2019;14(1): e13911. doi:https://doi.org/10.5812/jjnpp.13911.
   Web of Science ®Google Scholar
• Hosseinzadeh H, Parvardeh S. Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice. Phytomedicine. 2004;11(1):56–64.
   PubMed Web of Science ®Google Scholar
• Farkhondeh T, Samarghandian S, Shahri AMP, et al. The neuroprotective effects of thymoquinone: a review. Dose-response. 2018;16(2):1559325818761455.
   Web of Science ®Google Scholar
• Mohammadi A, Mansoori B, Baradaran B. Regulation of miRNAs by herbal medicine: an emerging field in cancer therapies. Biomed Pharmacother. 2017;86:262–270.
   PubMed Web of Science ®Google Scholar
• Gülşen İ, Ak H, Çölçimen N, et al. Neuroprotective effects of thymoquinone on the hippocampus in a rat model of traumatic brain injury. World Neurosurg. 2016;86:243–249.
   PubMed Web of Science ®Google Scholar
• Racine RJ. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr Clin Neurophysiol. 1972;32(3):281–294
   PubMedGoogle Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Agarwal V, Bell GW, Nam J-W, et al. Predicting effective microRNA target sites in mammalian mRNAs. elife. 2015;4:e05005.
   PubMed Web of Science ®Google Scholar
• Sticht C, De La Torre C, Parveen A, et al. miRWalk: an online resource for prediction of microRNA binding sites. PloS one. 2018;13(10):e0206239.
   PubMed Web of Science ®Google Scholar
• Huang Z, Shi J, Gao Y, et al. HMDD v3. 0: a database for experimentally supported human microRNA–disease associations. Nucleic Acids Res. 2019;47(D1):D1013–D1017.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127–D131.
   PubMed Web of Science ®Google Scholar
• Liu W, Wang X. Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data. Genome Biol. 2019;20(1):1–10.
   PubMed Web of Science ®Google Scholar
• Kehl T, Kern F, Backes C, et al. miRPathDB 2.0: a novel release of the miRNA pathway dictionary database. Nucleic Acids Res. 2020;48(D1):D142–D147.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Sato Y, Kawashima M, et al. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44(D1):D457–D462.
   PubMed Web of Science ®Google Scholar
• Krämer A, Green J, Pollard J Jr, et al. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics. 2014;30(4):523–530.
   PubMed Web of Science ®Google Scholar
• Jassal B, Matthews L, Viteri G, et al. The reactome pathway knowledgebase. Nucleic Acids Res. 2020;48(D1):D498–D503.
   PubMed Web of Science ®Google Scholar
• Choudhary KM, Mishra A, Poroikov VV, et al. Ameliorative effect of curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice. Eur J Pharmacol. 2013;704(1–3):33–40.
   PubMed Web of Science ®Google Scholar
• Dhir A. Pentylenetetrazol (PTZ) kindling model of epilepsy. Curr Protoc Neurosci . 2012;58(1):9–37.
   Google Scholar
• Venø MT, Reschke CR, Morris G, et al. A systems approach delivers a functional microRNA catalog and expanded targets for seizure suppression in temporal lobe epilepsy. Proc Natl Acad Sci U S A. 2020;117(27):15977–15988. doi:https://doi.org/10.1073/pnas.1919313117. PMID: 32581127; PMCID: PMC7355001.
   PubMed Web of Science ®Google Scholar
• Thakran S, Guin D, Singh P, et al. Genetic landscape of common epilepsies: advancing towards precision in treatment. Int J Mol Sci. 2020;21(20):7784.
   PubMed Web of Science ®Google Scholar
• McNamara JO. Kindling: an animal model of complex partial epilepsy. Ann Neurol. 1984;16(S1):S72–S76.
   PubMed Web of Science ®Google Scholar
• Löscher W. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure. 2011;20(5):359–368.
   PubMed Web of Science ®Google Scholar
• Grone BP, Baraban SC. Animal models in epilepsy research: legacies and new directions. Nat Neurosci. 2015;18(3):339–343.
   PubMed Web of Science ®Google Scholar
• Marescaux C, Micheletti G, Vergnes M, et al. A model of chronic spontaneous petit mal‐like seizures in the rat: comparison with pentylenetetrazol‐induced seizures. Epilepsia. 1984;25(3):326–331.
   PubMed Web of Science ®Google Scholar
• Kandratavicius L, Balista PA, Lopes-Aguiar C, et al. Animal models of epilepsy: use and limitations. Neuropsychiatr Dis Treat. 2014;1693. https://doi.org/10.2147/NDT.S50371
   PubMed Web of Science ®Google Scholar
• Shaterzadeh-Yazdi H, Noorbakhsh M-F, Hayati F, et al. Immunomodulatory and anti-inflammatory effects of thymoquinone. Cardiovasc Hematol Disord - Drug Targets. 2018;18(1):52–60
   PubMedGoogle Scholar
• Khan MA. Antimicrobial action of thymoquinone. In: Molecular and therapeutic actions of thymoquinone. Springer; 2018. p. 57–64.
   Google Scholar
• Staniek K, Gille L. Is thymoquinone an antooxidant. BMC Pharmacol. 2010;10:A9. doi:https://doi.org/10.1186/1471-2210-10-S1-A9.
   PubMedGoogle Scholar
• Landucci E, Mazzantini C, Buonvicino D, et al. Neuroprotective effects of thymoquinone by the modulation of ER stress and apoptotic pathway in in vitro model of excitotoxicity. Molecules. 2021;26(6):1592.
   PubMed Web of Science ®Google Scholar
• Khan MA, Tania M, Fu J. Epigenetic role of thymoquinone: impact on cellular mechanism and cancer therapeutics. Drug Discov Today. 2019;24(12):2315–2322.
   PubMed Web of Science ®Google Scholar
• Dong H, Dong B, Zhang N, et al. microRNA-182 negatively influences the neuroprotective effect of apelin against neuronal injury in epilepsy. Neuropsychiatr Dis Treat. 2020;16:327.
   PubMed Web of Science ®Google Scholar
• Li L, Peng W, Tian X. Protective effects and mechanisms of microRNA-182 on oxidative stress in RHiN. Open Life Sci. 2019;14(1):400–409.
   PubMed Web of Science ®Google Scholar
• Abdellatif M, van Rooij E. Differential expression of microRNAs in different disease states. Circ Res. 2012;110(4):638–650.
   PubMed Web of Science ®Google Scholar
• Duan X, Gan J, Peng DY, et al. Identification and functional analysis of microRNAs in rats following focal cerebral ischemia injury. Mol Med Rep. 2019;19(5):4175–4184.
   PubMed Web of Science ®Google Scholar
• Ding X, Sun B, Huang J, et al. The role of miR-182 in regulating pineal CLOCK expression after hypoxia-ischemia brain injury in neonatal rats. Neurosci Lett. 2015;591:75–80.
   PubMed Web of Science ®Google Scholar
• Wang X, Yin H, Rich AM, et al. MicroRNAs as biomarkers in molecular diagnosis of refractory epilepsy. Chin Neurosurg J. 2016;2(1):1–6.
   Google Scholar
• Henshall DC. MicroRNA and epilepsy: profiling, functions and potential clinical applications. Curr Opin Neurol. 2014 27;27(2):199.
   PubMed Web of Science ®Google Scholar
• Thulasingam S, Massilamany C, Gangaplara A, et al. miR-27b*, an oxidative stress-responsive microRNA modulates nuclear factor-kB pathway in RAW 264.7 cells. Mol Cell Biochem. 2011;352(1–2):181–188.
   PubMed Web of Science ®Google Scholar
• Xu W, Li F, Liu Z, et al. MicroRNA-27b inhibition promotes Nrf2/ARE pathway activation and alleviates intracerebral hemorrhage-induced brain injury. Oncotarget. 2017;8(41):70669.
   PubMedGoogle Scholar
• Kassab RB, El-Hennamy RE. The role of thymoquinone as a potent antioxidant in ameliorating the neurotoxic effect of sodium arsenate in female rat. Egypt J Basic Appl Sci. 2017;4(3):160–167.
   Google Scholar
• Binder DK, Croll SD, Gall CM, et al. BDNF and epilepsy: too much of a good thing? Trends Neurosci. 2001;24(1):47–53.
   PubMed Web of Science ®Google Scholar
• Re CJ, Batterman AI, Gerstner JR, et al. The molecular genetic interaction between circadian rhythms and susceptibility to seizures and epilepsy. Front Neurol. 2020;11. DOI:https://doi.org/10.3389/fneur.2020.00520
   Web of Science ®Google Scholar
• Lehtinen MK. Epilepsy clocks in. Sci Transl Med. 2017;9(416). https://doi.org/10.1126/scitranslmed.aaq1237
   Google Scholar
• Li P, Fu X, Smith NA, et al. Loss of CLOCK results in dysfunction of brain circuits underlying focal epilepsy. Neuron. 2017;96(2):387–401. e6.
   PubMed Web of Science ®Google Scholar
• Romano R, Bucci C. Role of EGFR in the nervous system. Cells. 2020;9(8):1887.
   PubMed Web of Science ®Google Scholar
• Bhalala OG, Srikanth M, Kessler JA. The emerging roles of microRNAs in CNS injuries. Nat Rev Neurol. 2013;9(6):328–339.
   PubMed Web of Science ®Google Scholar
• Janssen HLA, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med. 2013;368(18):1685–1694.
   PubMed Web of Science ®Google Scholar
• De Smaele E, Ferretti E, Gulino A. MicroRNAs as biomarkers for CNS cancer and other disorders. Brain Res. 2010;1338:100–111.
   PubMed Web of Science ®Google Scholar
• Scholer N, Langer C, Dohner H, et al. Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature. Exp Hematol. 2010;38(12):1126–1130.
   PubMed Web of Science ®Google Scholar
• Balakathiresan N, Bhomia M, Chandran R, et al. MicroRNA Let-7i is a promising serum biomarker for blast-induced traumatic brain injury. J Neurotrauma. 2012;29(7):1379–1387.
   PubMed Web of Science ®Google Scholar
• Liu DZ, Tian Y, Ander BP, et al. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab. 2010;30(1):92–101.
   PubMed Web of Science ®Google Scholar
• Gorter JA, Iyer A, White I, et al. Hippocampal subregionspecific microRNA expression during epileptogenesis in experimental temporal lobe epilepsy. Neurobiol Dis. 2013;62:508–520.
   PubMed Web of Science ®Google Scholar